Health systems are finding that the biggest challenge with GLP-1 medications isn’t starting patients on therapy — it’s keeping them on it. During a panel at Becker’s Spring Chief Pharmacy Officer Summit, pharmacy and physician leaders said adherence has emerged…
GLP-1s
Self-funded health systems have been navigating a costly GLP-1 landscape in recent years, and the issue has not seemed to lighten up — yet. Philadelphia-based Jefferson Health is one of the latest grappling with steep costs for its 65,000 employees.…
More than 130 medical, public health and patient advocacy organizations are raising concerns about recent changes to the CDC’s vaccine advisory panel, warning the updates could affect vaccine access and public confidence. The concerns follow an April 1 renewal of the Advisory…
Novo Nordisk said April 23 it plans to seek expanded FDA approval for its Ozempic pill in the second half of 2026, which would make the drug the first oral GLP-1 approved for children and adolescents with Type 2 diabetes. …
Amazon and Walmart have launched GLP-1 weight management programs within days of each other, signaling a broader shift as retailers, payers and drugmakers compete to control access to one of healthcare’s fastest-growing drug classes. Amazon’s One Medical program integrates primary…
Advertisement
CMS is holding off on its voluntary “Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth” model pilot for Medicare Part D, the agency confirmed to Becker’s April 21. Under BALANCE, CMS would negotiate lower GLP-1 prices for Medicaid programs…
More Wegovy prescriptions are being written as GLP-1 weight loss drugs gain traction across retail, telehealth and direct-to-consumer channels, according to an April 20 report from Truveta Research. The growth follows the FDA’s December approval of oral Wegovy (semaglutide) and…
Researchers at the University of Pennsylvania in Philadelphia have used AI to analyze more than 400,000 Reddit posts and identify potential GLP-1 side effects not fully captured in clinical trials. The analysis included posts from nearly 70,000 users discussing drugs…
Walmart has expanded its Better Care Services platform to include weight management support for customers using or considering GLP-1 therapies, including access to medications such as Foundayo (orforglipron). Walmart said the platform integrates virtual care, nutrition services and pharmacy access…
The FDA is requiring Eli Lilly to conduct extensive postmarketing studies for its newly approved GLP-1 pill Foundayo (orforglipron) to further assess potential safety risks. The agency said additional data is needed to evaluate risks, including major adverse cardiovascular events,…